Iradimed Corp (IRMD) Releases Earnings Results, Beats Expectations By $0.03 EPS

Iradimed Corp (IRMD) reported quarterly earnings results on Friday, Jul-29-2016. The company said it had a profit of $0.24 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.03. Analysts had a consensus of $0.21. The company posted revenue of $9.90 million in the period, compared to analysts expectations of $9.61 million. The company’s revenue was up 30.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.16 EPS.

Iradimed Corp closed down -0.71 points or -3.68% at $18.56 with 59,516 shares getting traded on Thursday. Post opening the session at $19.22, the shares hit an intraday low of $18.47 and an intraday high of $19.3 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

In a different news, on Jun 14, 2016, Monty K Allen (director) sold 2,275 shares at $20.00 per share price. According to the SEC, on Feb 22, 2016, Steven M. Nardi (VP of Manufacturing) sold 192 shares at $17.00 per share price. On Feb 22, 2016, Serge Novovich (director) sold 2,910 shares at $17.23 per share price, according to the Form-4 filing with the securities and exchange commission.

IRADIMED CORPORATION (IRADIMED) develops manufactures markets and distributes Magnetic Resonance Imaging (MRI) compatible products and provides non-magnetic intravenous (IV) infusion pump systems. The Company’s electromechanical medical devices and pumps contain magnetic and electronic parts which generate radio frequency (RF) noise create interference and are dangerous to operate in the presence of the magnet which drives an MRI. The Company’s MRidium 3860+ MRI compatible IV infusion pump system consists of non-ferrous parts ceramic ultrasonic motors non-magnetic mobile stands and other special features to deliver anesthesia and other IV fluids during various MRI procedures. As of December 31 2014 the Company had approximately 2300 MRI compatible IV infusion pump systems installed globally. Each system consists of an MRidium MRI compatible IV infusion pump mobile stand and disposable IV tubing sets.

Iradimed Corp

Leave a Reply

Iradimed Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Iradimed Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.